Cargando…
Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities
BACKGROUND: The pharmacological treatment of bipolar disorder has dramatically improved with multiple classes of agents being used as mood-stabilizers, including lithium, anticonvulsants, and atypical antipsychotics. However, the use of these medications is not without risk, particularly when a pati...
Autores principales: | McLaren, Kimberly D, Marangell, Lauren B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420249/ https://www.ncbi.nlm.nih.gov/pubmed/15104799 http://dx.doi.org/10.1186/1475-2832-3-7 |
Ejemplares similares
-
Current issues: women and bipolar disorder
por: Marangell, Lauren B.
Publicado: (2008) -
Late-Onset Bipolar Disorder: Considerations for Diagnosis and Treatment
por: McKenzie, Anna K, et al.
Publicado: (2023) -
Co-morbidity in Bipolar Disorder: A Retrospective Study
por: Munoli, Ravindra Neelakanthappa, et al.
Publicado: (2014) -
The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020) -
OBSESSIVE COMPULSIVE DISORDER:CO-MORBIDITY IN MANIC PHASE OF BIPOLAR AFFECTIVE DISORDER
por: Kalra, Harish, et al.
Publicado: (2002)